Profile
Abstract
Ulrich Laufs is Professor and Chief of Cardiology at Leipzig University Hospital.
Professor Laufs heads a research group focused on cellular and molecular mechanisms, and clinical studies of cardiovascular prevention with a special interest in lipid disorders. Additional research interests of the department include heart failure and cardiomyopathies, cardiac imaging, interventional cardiology and atrial fibrillation. He has > 550 publications listed medline that have been cited >38,000 times.
Laufs serves in the board of the German Society of Cardiology and the D•A•CH-Gesellschaft Herz-Kreislauf-Prävention, the federal drug commission of German Pharmacists and in several editorial boards of cardiovascular journals. His honors include the Population Sciences Award of the European Society of Cardiology, the Paul Martini Award, and the Albert Fraenkel Award of the German Cardiac Society.
Professional career
- since 07/2017
Professor of Cardiology, Leipzig University & Chief of Cardiology, Leipzig University Hospital - 01/2008 - 06/2017
Professor, Klinisch-Experimentelle Medizin, Saarland University, Homburg - 01/2004 - 12/2004
Attending physician for cardiology, angiology and intensive care medicine, Saarland University, Homburg - 01/1998 - 12/2000
Fellow, Division of Cardiology, University of Köln - 01/1996 - 12/1997
DFG Research Fellow, Brigham & Women’s Hospital, Harvard University, Boston, USA - 01/1995 - 12/1996
Residency, Department of Medicine, University of Cologne
Education
- 09/1988 - 09/1990
Studies in Medicine, Medical School and School of Philosophy, Universities of Bochum & Hamburg, Germany - 12/1994
Doctorate: “Lokalisation von G Proteinen im Herzen durch in-situ Hybridisierung. Anreicherung von Gsα -, Giα2- und Goα im Erregungsleitungssystem”, Supervisor: Prof. Hasso Scholz, Hamburg University, „summa cum laude“ - 01/2004
Habilitation “Kardiovaskuläre Bedeutung von Rho GTPasen”, Mentor: Prof. Michael Böhm, Saarland University, Homburg, Germany.
Panel Memberships
- since 01/2024
Secretary, European Atherosclerosis Society - since 01/2023
Elected Board Member, German Cardiac Society (DGK) - 01/2021 - 12/2023
Chair, D•A•CH-Gesellschaft Herz-Kreislauf-Prävention e.V - 01/2016 - 12/2018
Speaker, Working Group Heart Failure, German Cardiac Society - 01/2005 - 12/2015
Speaker, Working Group Heart and Brain, German Cardiac Society
- MD-LEICS: Modern Diseases LEIpzig - Clinician Scientist programKörner, AntjeDuration: 01/2023 – 12/2026Funded by: DFG Deutsche ForschungsgemeinschaftInvolved organisational units of Leipzig University: Klinik und Poliklinik für Kinder- und Jugendmedizin
- ApoC3 and the inflamasom – new serum biomarkers for patients with nonalcoholic steatohepatitis (NASH)Berg, ThomasDuration: 01/2022 – ongoingFunded by: Haushaltsmittel (TG51, Overhead)Involved organisational units of Leipzig University: Medizinische Klinik und Poliklinik - Onkologie, Gastroenterologie, Hepatologie, Pneumologie und Infektiologie (II); Medizinische Klinik und Poliklinik - Kardiologie
- Peripheral Drivers of Heart Failure Progression (PEDAL-HF)Thiele, HolgerDuration: 01/2022 – 12/2025Funded by: Haushaltsmittel (TG51, Overhead)Involved organisational units of Leipzig University: Klinik für Innere Medizin/Kardiologie
- Schunk, S. J.; Kleber, M. E.; Maerz, W. et al.Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortalityEuropean heart journal. 2021. 42 (18). pp. 1742–1756.
- Zewinger, S.; Reiser, J.; Jankowski, V. et al.Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activationNature immunology. 2020. 21 (1). pp. 30–41.
- Gaul, S.; Leszczynska, A.; Alegre, F. et al.Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosisJournal of hepatology. 2021. 74 (1). pp. 156–167.
- Werner, C. M.; Hecksteden, A.; Morsch, A.; Zundler, J.; Wegmann, M.; Kratzsch, J.; Thiery, J.; Hohl, M.; Bittenbring, J. T.; Neumann, F.; Böhm, M.; Meyer, T.; Laufs, U.Differential effects of endurance, interval, and resistance training on telomerase activity and telomere length in a randomized, controlled studyEuropean heart journal. 2019. 40 (1). pp. 34–46.
- Gaul, S.; Rubil, S.; Endres, M.; Princen, H. M. G.; Boeckel, J.-N.; Winter, K.; Werner, C. M.; Laufs, U.Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP miceScientific Reports. 2019. 9 (1).
- Andere Ehrungen: Elite Reviewer Awards, European Heart Journalshow detailsLaufs, Ulrich (Medizinische Klinik und Poliklinik - Kardiologie)awarded in 2022.
- Andere Stipendien/Forschungspreise: Albert-Fraenkel-Preis, Deutsche Gesellschaft für Kardiologieshow detailsLaufs, Ulrich (Medizinische Klinik und Poliklinik - Kardiologie)awarded in 2007.
- Andere Ehrungen: Schwarz-Monheim Award, Deutsche Gesellschaft für Angiologieshow detailsLaufs, Ulrich (Medizinische Klinik und Poliklinik - Kardiologie)awarded in 2004.
- Andere Stipendien/Forschungspreise: Population Sciences Award, European Society of Cardiology, first placeshow detailsLaufs, Ulrich (Medizinische Klinik und Poliklinik - Kardiologie)awarded in 2004.
- Andere Ehrungen: Paul-Martini-Awardshow detailsLaufs, Ulrich (Medizinische Klinik und Poliklinik - Kardiologie)awarded in 2002 by Paul-Martini-Stiftung.
Research fields
Cardiology
Contact for media inquiries
Fax: +49 341 97-12659
Phone: +49 341 97-12650